Foundation for the National Institutes of Health: partnering to tackle cancer
The Foundation for the National Institutes of Health (FNIH) takes on cancer through public-private research…
For our special newsletter on cancer, Labiotech had the opportunity to put the same question…
By Neil Ward, vice President and general manager, PacBio EMEA We’ve known for a long…
By Soheila Borhani, School of Biomedical Informatics, University of Texas Health Science Center Since its…
The Foundation for the National Institutes of Health (FNIH) takes on cancer through public-private research…
By Victoria Zazulina, M.D., head of development unit, oncology, for the healthcare business of Merck…
By Michael Pisano, executive vice president, proteomics, Discovery Life Sciences In oncology, characterizing genetic markers…
Innovation in cancer research is happening at an accelerated rate, but the current healthcare system…
Everyone imagines a world without cancer, but getting there is difficult. With World Cancer Day…
By Ian B. Walters, chief executive officer and chairman, Portage Biotech In recent years, PD-1/PD-L1…
By Oxford BioDynamics Cancer care is in urgent need of effective tests to determine the…
Labiotech recently asked several biotech experts the same question about tackling cancer, for a special…
by Martin Slater, Cresset Discovery Computational chemistry offers a fast and innovative approach to drug…